BioStock: FluoGuide accelerates precision cancer surgery
Danish based biotech FluoGuide is combining fluorescence-guided imaging innovation with global medtech partnerships to support better outcomes for cancer patients. With recent regulatory milestones and strong financial backing, the company is entering a new phase of clinical and commercial growth. BioStock spoke to CEO Morten Albrechtsen to gain deeper insight into FluoGuide’s journey and future direction.
Read the full article at biostock.se:
https://biostock.se/en/2025/11/fluoguide-accelererar-precisionskirurgi-vid-cancer/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se